- Home
- SCS vs INVA Comparison
SCS vs INVA Comparison
Compare SCS & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCS
- INVA
- Stock Information
- Founded
- SCS 1912
- INVA 1996
- Country
- SCS United States
- INVA United States
- Employees
- SCS N/A
- INVA N/A
- Industry
- SCS Office Equipment/Supplies/Services
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- SCS Consumer Discretionary
- INVA Health Care
- Exchange
- SCS Nasdaq
- INVA Nasdaq
- Market Cap
- SCS 1.6B
- INVA 1.3B
- IPO Year
- SCS 1998
- INVA 2004
- Fundamental
- Price
- SCS $13.23
- INVA $18.90
- Analyst Decision
- SCS Strong Buy
- INVA Buy
- Analyst Count
- SCS 2
- INVA 1
- Target Price
- SCS $17.00
- INVA N/A
- AVG Volume (30 Days)
- SCS 471.8K
- INVA 575.7K
- Earning Date
- SCS 12-17-2024
- INVA 11-06-2024
- Dividend Yield
- SCS 3.02%
- INVA N/A
- EPS Growth
- SCS 125.40
- INVA 46.55
- EPS
- SCS 1.06
- INVA 0.99
- Revenue
- SCS $3,136,200,000.00
- INVA $352,745,000.00
- Revenue This Year
- SCS $2.70
- INVA $14.10
- Revenue Next Year
- SCS $3.08
- INVA N/A
- P/E Ratio
- SCS $12.48
- INVA $19.08
- Revenue Growth
- SCS N/A
- INVA 21.46
- 52 Week Low
- SCS $11.50
- INVA $13.41
- 52 Week High
- SCS $14.74
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- SCS 55.58
- INVA 35.97
- Support Level
- SCS $13.07
- INVA $18.40
- Resistance Level
- SCS $13.99
- INVA $21.28
- Average True Range (ATR)
- SCS 0.32
- INVA 0.61
- MACD
- SCS 0.11
- INVA -0.08
- Stochastic Oscillator
- SCS 61.42
- INVA 17.36
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands such as Steelcase, AMQ, Coalesse, Designtex, and others offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas which generates key revenue, and International.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.